West Pharmaceutical Services, Inc.

About West Pharmaceutical Services, Inc.

West is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of lifesaving and life-enhancing medicines for patients. We are guided by our core values of Passion for Customers, Leadership in Quality and One West team and these values underpin our purpose to improve patient’s lives. With nearly a century of experience, we work together with our customers to support patient health and fuel a brighter future with product innovation. 
West works by the side of customers from concept to patient to develop products that promote the efficiency, reliability and safety of the world’s pharmaceutical drug supply.

  • US
  • 2017
    On CPHI since
  • 4
  • 5000+
Company types
Drug delivery device Supplier/Manufacturer
Packaging supplier/manufacturer
Primary activities
Contract Manufacturer
Laboratory Services
Medical Devices
Packaging & drug delivery
Regulatory Affairs
Contact info
  • 530 Herman O. West Drive, 19341, Exton, Pennsylvania, United States
Meet us at

CPHI Barcelona 2023

Fira Barcelona Gran Via, Spain
24-26 October 2023

Pharmapack Europe 2024

Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
24 & 25 January 2024

Products from West Pharmaceutical Services, Inc. (15)

  • Daikyo® Crystal Zenith® 2.25mL Insert Needle Syringe System

    Product Daikyo® Crystal Zenith® 2.25mL Insert Needle Syringe System

    The Daikyo® Crystal Zenith® (CZ) 2.25mL insert needle is a break-resistant, polymer syringe of choice to protect larger volume sensitive molecules during self-administration. For drug developers wishing to avoid glass, this syringe system protects delicate molecules as there is no silicone oil added for fu...
  • West Ready Pack™ with NovaPure® Stoppers, Flip-Off® CCS Seals and Corning Valor® RTU VIals with SG EZ-fill® Technology

    Product West Ready Pack™ with NovaPure® Stoppers, Flip-Off® CCS Seals and Corning Valor® RTU VIals with SG EZ-fill® Technology

    Through a strategic partnership with Corning, one of the world’s leaders in glass science, West is redefining the future of containment solutions by creating a truly integrated system that will help de-risk customers’ drug development and manufacturing processes by providing comprehensive product informati...
  • Smartdose® On-Body Delivery System Platform (OBDS)

    Product Smartdose® On-Body Delivery System Platform (OBDS)

    The SmartDose platform offers a wearable, subcutaneous injector with an integrated drug delivery system that incorporates human factors and usability testing to deliver a truly patient-centric approach to self-administration.
  • NovaPure® Components

    Product NovaPure® Components

    NovaPure® components have quality built in from the start. West has developed a comprehensive quality target product profile (QTPP) based on the needs of our customers and end users.
  • Daikyo Crystal Zenith® vials

    Product Daikyo Crystal Zenith® vials

    With glass-like transparency, but superior break resistance and low risk of chemical interactions, Daikyo Crystal Zenith® vials can help avoid issues including delamination, and particulates.
  • Daikyo Crystal Zenith® Syringe Systems

    Product Daikyo Crystal Zenith® Syringe Systems

    The Daikyo Crystal Zenith® Insert Needle and Luer Lock Syringe systems were designed to maintain purity, integrity and efficacy of premium biopharmaceutical therapies.
  • Prefilled Syringes

    Product Prefilled Syringes

    An ideal choice for single- and multi-dose drugs, West components for prefillable systems help to ensure a more consistent injection rate to help patients receive accurate dosing with their treatment regimen.
  • Contract Manufacturing Services

    Product Contract Manufacturing Services

    The West Contract Manufacturing team is focused on serving the needs of healthcare companies by providing a single-source solution from product conceptualization through manufacturing and final packaging.  
  • Vial Adapter Systems

    Product Vial Adapter Systems

    Reconstitution devices enhance drug reconstitution, mixing and transfer through advanced technologies.
  • Ready pack® system

    Product Ready pack® system

    The West Ready Pack® system is comprised of high-quality primary and secondary packaging components. The Ready Pack system consists of sterilized NovaPure® stoppers, Flip-Off® seals, vials and vial adapters.
  • Selfdose™ patient-controlled injector

    Product Selfdose™ patient-controlled injector

    The SelfDose patient-controlled injector is an off-the-shelf delivery system that is ergonomically designed for optimal patient administration.
  • Analytical services

    Product Analytical services

    West offers analytical services for specialized testing and analysis to evaluate the compatibility of drug products with their packaging or administration system for pharmaceutical and biopharma customers.

West Pharmaceutical Services, Inc. Resources (4)

  • News West Collaborates with Corning for Sustainable Drug Delivery

    West and Corning Launch Viridian™ Vials that provide both performance and sustainability to the healthcare industry
  • Webinar Design of a New Elastomer Formulation for Lyophilization Applications

    4040/40 elastomer formulation was designed with ‘future in mind’ to meet the ever-increasing performance & quality standards expected of primary drug packaging. The presentation will summarize the extensive Quality by Design (QbD) process that was undertaken to develop this new formulation as well as considerations taken for closure design dedicated for Lyophilization applications. Details of the extensive characterization that was performed as part of product development as well as data to demonstrates the overall performance of the new rubber formulation for lyophilization stoppers with respect to Extractables/Leachables, Particulates, Moisture, Container Closure Integrity (CCI), Particles and Manufacturability will be presented.
  • Webinar Selection of a Primary Container Closure System Capable of Maintaining Closure Integrity during Cold Storage at -80°C

    Advanced therapies are rapidly becoming a reality, targeting unmet patient needs and treatments for diseases with limited therapeutic options. Some advanced therapies, such as gene therapy and mRNA, require cryopreservation due to their fragile nature at room temperature, putting unprecedented expectations on the packaging systems to maintain Container Closure Integrity (CCI) during storage at -80°C. The quality, patient safety, and high value of these therapeutics can be jeopardized if the chosen containment system doesn’t consistently maintain a sterile barrier from when the drug is packed through to administration to the patient. During cooling between room temperature and -80°C, common vial system components such as glass vials, elastomeric closures, and aluminum seals exhibit contraction and changes in physico-mechanical properties. These changes in material properties and component dimensions may affect the system’s ability to maintain closure integrity, resulting in the formation of transient leaks.
    In this joint study conducted by West and Corning, we discuss results from four experiments that explore the influences of capping pressure, cooling rate, dimensional changes, and long-term storage at -80°C on the system’s ability to maintain closure integrity. Both Helium leak testing and laser-based gas headspace analysis were used to monitor the closure integrity. The key result of the study is a combination of vial system components and capping conditions that maintain container closure integrity when cooled to and stored at -80°C
  • Webinar How Market Trends Drive Innovation and Enable the Pharmaceutical Pipeline

    Our healthcare industry is evolving. The move from IV to SC injection is being driven by lifecycle management, biosimilar adoption, and the hospital to home trend. Molecules are getting more complex, and patients drive the preference for self-administration resulting in the need for more complex combination product development and quick scale up. We will present innovative solutions to these challenges to help speed up drug development and enable patient choice with: A 2.25mL polymer container system for auto-injectors which protects sensitive molecules A large volume cartridge plunger to enable primary containment within an on-body delivery system A small pack, high quality glass containment system to enable quick delivery in early-stage development